Mucosal human immunodeficiency virus vaccine late pre-clinical evaluation [ 2018 - 2019 ]

Research Grant

Researchers: A/Pr Charani Ranasinghe (Principal investigator) ,  Prof Anthony Kelleher ,  Prof Damian Purcell ,  Prof Stephen Kent

Brief description Despite many candidate vaccines entering clinical development for protection against HIV, none has yet been successful. This proposal centres on late preclinical development for a novel mucosal vaccine strategy for HIV, which combines a preclinically-proven approach to generating strong T cell immune responses, with an existing approach to generating broadly neutralising antibody responses to HIV. Proof of synergy between these approaches will lead directly to clinical development.

Funding Amount $AUD 583,369.51

Funding Scheme Development Grants

Notes Development Grant